Letters, Testimony & Comments

July 10, 2012
Dear Chairman Lucas and Ranking Member Peterson: Our members are engaged in the development, use and future utilization of agricultural products derived through modern biotechnology, and support comprehensive and efficient regulation of these...
July 7, 2012
Dear Sir/Madam: The Biotechnology Industry Organization (BIO) thanks the Food and Drug Administration (FDA or Agency) for the opportunity to submit comments on “Risk Evaluation and Mitigation Strategy Assessments: Social Science...
June 28, 2012
The U.S. Intellectual Property Rights Attaché Program has had significant success and holds immense promise in helping to enhance IP protection abroad for U.S. interests. This international focus is imperative, given that that more than 60...
June 21, 2012
Senators Sanders and Boxer have introduced an amendment that will result in costly and extreme food labeling requirements. Senate Amendment 2310 to the Agriculture Reform, Food and Jobs Act of 2012 opens the door for states to require that...
June 21, 2012
The Biotechnology Industry Organization (BIO), which represents more than 1,100 biotechnology companies, academic institutions, state biotechnology centers, and related organizations around the world, strongly opposes the Sanders-Boxer Amendment...
June 20, 2012
 Thank you.  It's GREAT to be in BOSTON! MANY people think of BOSTON...as one of the world's GREATEST centers of excellence in EDUCATION...and it CERTAINLY IS. With the Boston CELTICS...RED SOX...BRUINS...and New England...
June 19, 2012
We just heard our chairman Tom Watkins say "We're doing big things." Sounds good, but is that just hype, or is it for real? It's real. Together we do really big things. Today, I want to brag about some of the really big...
June 18, 2012
The Federal Circuit Court previously concluded that the claimed isolated genomic DNA and cDNA molecules in this case are patentable compositions of matter. Nothing in Mayo Collaborative Services v. Prometheus Laboratories, Inc., 132 S. Ct. 1289 (...
June 15, 2012
  The Biotechnology Industry Organization (BIO) appreciates the opportunity to comment on the Institute of Medicine’s (IOM’s) new report entitled,Ranking Vaccines: A Prioritization Framework, which was developed for the National...
June 15, 2012
  The Biotechnology Industry Organization (BIO) appreciates the opportunity to comment on the Institute of Medicine’s (IOM’s) new report entitled,Ranking Vaccines: A Prioritization Framework, which was developed for the National...
June 12, 2012
On behalf of the 23 undersigned industrial, environmental, food and agricultural biotechnology companies, we write to express our concerns over the pending appeal in the case of Association for Molecular Pathology et al. v. Myriad Genetics et al (...
May 31, 2012
Dear Sir/Madam: BIO thanks the FDA for the opportunity to provide comments on Modernizing the Regulation of Clinical Trials and Approaches to Good Clinical Practice. BIO strongly supports efforts by FDA, industry, academia, and patient groups to...
May 30, 2012
Dear Speaker Boehner and Minority Leader Pelosi: On behalf of the Biotechnology Industry Organization (BIO), I am writing to express our support for H.R. 5651, the Food and Drug Administration Reform Act of 2012, which includes a reauthorization...
May 21, 2012
Testimony of the Honorable James C. Greenwood President and CEO, Biotechnology Industry Organization Subcommittee on Conservation, Energy, and Forestry Committee on Agriculture U.S. House of Representatives May 18, 2012 The...
May 21, 2012
Comments of Biotechnology Industry Organization on EPA’s Science Advisory Board Deliberative Draft Report for Biogenic Carbon Accounting May 10, 2012  The Biotechnology Industry Organization (BIO) appreciates the opportunity to...
May 21, 2012
September 30, 2011 Det 1 AFRL/PKMD ATTN: Laura J. Ortiz 2310 Eighth Street, Bldg 167 Wright-Patterson AFB OH 45433-7801 Via email at: laura.ortiz@wpafb.af.mil Re: Comments of the Biotechnology Industry Organization in response to RFI-...
May 21, 2012
    Dear Sir/Madam:   The Biotechnology Industry Organization (BIO) thanks the Food and Drug Administration (FDA) for the opportunity to submit comments on the “Draft Guidance for Industry Drug Interaction Studies...
May 18, 2012
Re:      Proposed Project: Enrollment and Recertification of Entities in the 340B Drug Pricing Program (OMB No. 0915–0327)—Revision Dear Commander Pedley:         ...